IRIS
VILLANI, ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.149
NA - Nord America 2.441
AS - Asia 1.979
SA - Sud America 382
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 2
Totale 8.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.389
IE - Irlanda 913
SG - Singapore 842
IT - Italia 547
CN - Cina 522
SE - Svezia 450
UA - Ucraina 368
BR - Brasile 333
RU - Federazione Russa 267
HK - Hong Kong 265
DE - Germania 174
FR - Francia 111
VN - Vietnam 106
FI - Finlandia 98
IN - India 76
GB - Regno Unito 71
AT - Austria 41
TR - Turchia 36
PL - Polonia 24
BD - Bangladesh 22
CA - Canada 22
ID - Indonesia 19
AR - Argentina 18
BE - Belgio 18
MX - Messico 17
NL - Olanda 15
CZ - Repubblica Ceca 14
JP - Giappone 12
AE - Emirati Arabi Uniti 11
IQ - Iraq 10
ZA - Sudafrica 10
EC - Ecuador 8
PK - Pakistan 8
RO - Romania 8
LT - Lituania 7
SA - Arabia Saudita 7
VE - Venezuela 7
CO - Colombia 6
EG - Egitto 6
UZ - Uzbekistan 6
ES - Italia 5
EU - Europa 5
CL - Cile 4
HU - Ungheria 4
IL - Israele 4
IR - Iran 4
LB - Libano 4
MA - Marocco 4
PH - Filippine 4
CH - Svizzera 3
DZ - Algeria 3
HN - Honduras 3
KE - Kenya 3
KR - Corea 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
KG - Kirghizistan 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CD - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GN - Guinea 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
JO - Giordania 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NA - Namibia 1
NE - Niger 1
NO - Norvegia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 7.995
Salva come PNG Salva come JPEG
Città #
Dublin 911
Singapore 401
Nyköping 308
Hong Kong 263
Chandler 251
Jacksonville 216
Dallas 208
Ashburn 185
Beijing 152
Santa Clara 135
Wilmington 112
Dearborn 103
Princeton 89
New York 72
Helsinki 71
Moscow 58
Nanjing 57
The Dalles 57
Munich 52
Ann Arbor 51
Foggia 48
Rome 36
Ho Chi Minh City 34
Bari 31
Los Angeles 28
São Paulo 27
Hanoi 23
Nanchang 23
Vienna 23
Des Moines 22
Milan 19
Nuremberg 19
Shenyang 19
Brussels 18
Kraków 18
San Mateo 18
Kunming 17
London 15
Brooklyn 14
Gravina in Puglia 14
Hebei 14
Gravina In Puglia 13
Jakarta 13
San Severo 13
Stevenage 13
Boardman 12
Falkenstein 12
Norwalk 12
Caserta 11
Delhi 11
Hangzhou 11
Naples 11
Seattle 11
Tianjin 11
Woodbridge 11
Düsseldorf 10
Jiaxing 10
Stockholm 10
Turku 10
Zhengzhou 10
Brno 9
Buffalo 9
Houston 9
Manfredonia 9
Orange 9
Toronto 9
Assago 8
Belo Horizonte 8
Cagliari 8
Chicago 8
Council Bluffs 8
Frankfurt am Main 8
Guangzhou 8
San Francisco 8
Shanghai 8
Tokyo 8
Atlanta 7
Biên Hòa 7
Boston 7
Changsha 7
Falls Church 7
Venice 7
Ariano Irpino 6
Chennai 6
Curitiba 6
Jinan 6
Montreal 6
Nembro 6
Rio de Janeiro 6
Wuhan 6
Bologna 5
Borås 5
Campinas 5
Como 5
Haiphong 5
Johannesburg 5
Martina Franca 5
Mexico City 5
Palermo 5
Phoenix 5
Totale 4.721
Salva come PNG Salva come JPEG
Nome #
Direct-acting antivirals (daas) increase the serum vegf level in patients with chronic hepatitis c: a rationale for tumor recurrence 263
Strategie per la gestione del paziente HBV+ in terapia con immunosoppressori 190
Ulcere da decubito, prevenzione e trattamento. 180
Liver toxicity induced by amiodarone is dependent on mitochondria Complex I impairment, OXPHOS uncoupling and cardiolipin peroxidation. 163
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 138
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 133
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 131
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 126
To be or not to be: A two years surveillance for a CA 19-9 persistent elevation before cancer diagnosis and bone metastases 125
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 124
Diagnostic reliability of the procalcitonin serum marker in septic frail patient 115
Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir 112
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials 111
Effects of dietary fatty acids and cholesterol excess on liver injury: a lipidomic approach 109
Amiodarone induces liver toxicity by impairing liver mitochondria bioenergetics and redox balance. 107
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients with Circulating Cryoglobulins 104
Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study 102
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications 100
Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C 95
null 95
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis 94
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 94
Treatment of chronic HCV infection in the era of protease inhibitors 93
Direct-acting antivirals restore systemic redox homeostasis in chronic HCV patients (Q1 WoS) 93
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry 91
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 91
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 90
HOW OFTEN HAVE WE SAID: IF I HAD THOUGHT OF IT BEFORE? 88
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 87
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 86
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation (Q1 WoS) 86
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 85
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 83
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 82
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 81
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 81
Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation 81
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 81
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model 81
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 80
Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry 79
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 79
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 79
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 78
Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: Analysis of 944 patients in Apulia, Italy 78
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry 77
Age, mitochondria and bladder cancer 77
Asymptomatic saccular portal vein aneurysm: a case report and review of the literature 77
High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases 75
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 75
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 74
Unmet clinical questions in elderly patients with locally advanced and metastatic bladder cancer 73
Oxysterols and redox signaling in the pathogenesis of non alcoholic fatty liver disease. 71
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 71
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation 69
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 69
In-hospital mortality and length of stay in cirrhotic patients with sepsis treated with non-selective beta-blockers 68
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 67
Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 66
Molecular mechanisms involved in HCC recurrence after direct-acting antiviral therapy 66
Direct-acting antivirals for HCV treatment in older patients: A systematic review and meta-analysis 65
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 65
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 63
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry 62
The dual role of glutamatergic neurotransmission in Alzheimer’s disease: From pathophysiology to pharmacotherapy 61
The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in alzheimer’s disease 61
null 60
Monocyte bioenergetics: An immunometabolic perspective in metabolic dysfunction-associated steatohepatitis 60
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 60
Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 60
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 60
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression (Q1 WoS) 58
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry 58
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 58
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 57
THU-323-Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 56
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 56
Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysis 56
US-GUIDED PROBE POSITIONING DOES NOT IMPROVE APPLICABILITY BUT REDUCES VARIABILITY IN LIVER STIFFNESS (FIBROSCAN) MEASUREMENT 55
Two-Dimensional Shear Wave Elastography Versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C 55
Assessing the impact of COVID-19 on liver cancer management (CERO-19) 55
A Review on Biological Effects of Ultrasounds: Key Messages for Clinicians 54
Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the "less is more" perspective 53
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 53
The GLP-1 receptor agonist Exendin-4 modulates hippocampal NMDA-receptor signalling in aged rats and improves cognitive impairment in diabetic elderly patients 51
Lipid metabolism in development and progression of hepatocellular carcinoma 51
INSULINEMIC RESPONSE CURVE AFTER ORAL GLUCOSE TOLERANCE TEST IDENTIFIES EARLY ALTERATIONS OF GLUCOSE METABOLISM IN PATIENTS AFFECTED BY CHRONIC LIVER DISEASE 50
Convergence of disciplines: a systematic review of multidisciplinary development approaches in artificial intelligence 49
Impatto della terapia con Peg-interferone o entecavir sulla fibrosi epatica mediante elastomeri: osservazione dopo 4 anni 49
Pharmacological and toxicological effects of phytocannabinoids and recreational synthetic cannabinoids: Increasing risk of public health 49
The effect of direct-acting antivirals on hepatocellular carcinoma recurrence: still waiting for the turning point 47
Eradication of HCV by direct antiviral agents restores mitochondrial function and energy homeostasis in peripheral blood mononuclear cells 47
Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry 46
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 45
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 45
Liver fibrosis by FibroScan is highly prevalent in type 2 diabetic patients with NAFLD and fairly normal liver enzymes but increased uric acid 44
Low Diagnostic Accuracy of Transthoracic Ultrasound for the Assessment of Spontaneous Pneumothorax in the Emergency Setting: A Multicentric Study 43
Exploring the Relationship between Epicardial Fat Thickness and Coronary Revascularization: Implications for Cardiovascular Health 43
Tocilizumab and liver injury in patients with COVID-19 42
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 42
Totale 7.963
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.070
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021466 0 0 0 0 0 20 79 116 118 86 13 34
2021/2022550 28 10 17 10 45 35 38 40 86 93 27 121
2022/20231.979 209 85 89 51 85 159 28 152 1.017 17 49 38
2023/2024425 55 46 16 20 28 90 17 29 7 4 9 104
2024/20251.851 121 14 52 62 75 215 223 117 450 127 223 172
2025/20261.780 231 301 462 461 310 15 0 0 0 0 0 0
Totale 8.509